February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

On Tuesday March 1st, 2022 Jesper J. Lange, CEO will be participating in a panel at the PCMA Business Forum 2022 in Orlando, Florida under the title “Unlocking the Value of PBM & Small Pharmaceutical Manufacturer Relationships”.

During this panel discussion Mr. Lange will focus on how SMEs (Small and Medium-sized Enterprises), PBM’s and Payers can more effectively work together in a manner that motivates continued innovation from SMEs in development of new therapies for patients and take into consideration the vast differences in scale of economics between SMEs and Big Pharma. Mr. Lange will advocate for programs that supports SMEs and even out the inherent burden SMEs are facing in market access and pricing when introducing new drugs on the US market.

Please visit events.pcmanet.org for more information about the event.